Saturday 1 June 2019

Prescription drug costs steadily soar, yet price transparency is lacking: A new study found ‘continual, marked, annual increases’ of the country’s 49 most popular brand-name drugs. “It is especially concerning to see drugs in the same class having increases that appear to be coordinated.”

Prescription drug costs steadily soar, yet price transparency is lacking: A new study found ‘continual, marked, annual increases’ of the country’s 49 most popular brand-name drugs. “It is especially concerning to see drugs in the same class having increases that appear to be coordinated.” submitted by /u/mvea
[link] [comments]


from Health http://bit.ly/2WebF4h
via IFTTT

No comments:

Post a Comment